"Usual care" for major depression in the 1990s: Characteristics and expert-estimated outcomes

American Journal of Psychiatry

Volumn 160, Issue 4, 2003, Pages 720-726

  Horvitz Lennon, Marcela ^a,b   Normand, Sharon Lise T ^a   Frank, Richard G ^a   Goldman, Howard H ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b CAMBRIDGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DATA BASE; DRUG EFFICACY; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MEDICAL SPECIALIST; PREMENOPAUSE; PRIORITY JOURNAL; PROBABILITY; PSYCHOTHERAPY; REMISSION; SYMPTOMATOLOGY; ADOLESCENT; ADULT; AGE; AMBULATORY CARE; DEPRESSION; EXPERT WITNESS; HEALTH PERSONNEL ATTITUDE; HEALTH SERVICES RESEARCH; INSURANCE; META ANALYSIS; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PERSONNEL; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SEX DIFFERENCE; STANDARD; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ATTITUDE OF HEALTH PERSONNEL; DEPRESSIVE DISORDER; EXPERT TESTIMONY; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE CLAIM REPORTING; LITHIUM; META-ANALYSIS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RESEARCH PERSONNEL; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 0037797425     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.4.720     Document Type: Article

References (32)

1. Lebowitz BD, Rudorfer MV: Treatment research at the millennium: from efficacy to effectiveness (editorial). J Clin Psychopharmacol 1998; 18:1
2. National Advisory Mental Health Council's Clinical Treatment and Services Research Workgroup: Bridging Science and Service. Bethesda, Md, National Institutes of Health, National Institute of Mental Health, 1999
3. Wells KB: Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999; 156:5-10
4. Blazer DG, Kessler RC, McGonagle KA, Swartz MS: The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994; 151:979-986
5. Murray CJL, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-1442
6. Depression Guideline Panel: Depression in Primary Care, vol II: Treatment of Major Depression: Clinical Practice Guideline 5: AHCPR Publication 93-0550. Rockvilte, Md, Agency for Health Care Policy and Research, 1993
7. Treatment of Depression: Newer Pharmacotherapies: AHCPR Publication No. 99-E014. Rockville, Md, Agency for Health Care Policy and Research, 1999
8. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, Shea T: Time to recovery, chronicity, and levels of psychopathology in major depression. Arch Gen Psychiatry 1992; 49:809-816
9. Wells KB, Sturm R, Sherbourne C, Meredith L: Caring for Depression. Cambridge, Mass, Harvard University Press, 1996
10. Coyne JC, Klinkman MS, Gallo SM, Schwenk TL: Short-term outcomes of detected and undetected depressed primary care patients and depressed psychiatric patients. Gen Hosp Psychiatry 1997; 19:333-343
11. Simon GE, Von Korff M, Rutter CM, Peterson DA: Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry 2001; 58:395-401
12. Teasdale JD, Fennell MJV, Hibbert GA, Amies PL: Cognitive therapy for major depressive disorder in primary care. Br J Psychiatry 1984; 144:400-406
13. Scott MJ, Stradling SG: Group cognitive therapy for depression produces clinically significant reliable change in community-based settings. Behavioural Psychotherapy 1990; 18:1-19
14. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, Robinson P, Russo J: Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995; 273:1026-1031
15. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, Simon GE, Walker E: A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53:924-932
16. Simon G, VonKorff M, Heiligenstein JH, Revicki DA, Grothaus L, Katon W, Wagner EH: Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996; 275:1897-1902
17. Schulberg HC, Block M, Madonia MJ, Scott P, Lave J, Rodriguez E, Coulehan JL: The "usual care" of major depression in primary care practice. Arch Fam Med 1997; 6:334-339
18. Katon W, Von Korff M, Lin E, Simon G, Wagner E, Unützer J, Bush T, Russo J, Ludman E: Stepped collaborative care for primary care patients with persistent symptoms of depression. Arch Gen Psychiatry 1999; 56:1109-1115
19. Simon GE, Von Korff M, Rutter C, Wagner E: Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. Br Med J 2000; 320:550-554
20. Young A, Klap R, Sherbourne C, Wells KB: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001; 58:55-61
21. Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unützer J, Miranda J, Carney MF, Rubenstein LV: Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 2000; 283:212-220
22. Frank RG, McGuire TG, Normand SL, Goldman HH: The value of mental health care at the system level: the case of treating depression. Health Aff (Millwood) 1999; 18:71-88
23. Normand SL, Frank RG, McGuire TG: Using elicitation techniques to estimate the value of ambulatory treatments for major depression. Med Decis Making 2002; 22:245-261
24. Berndt ER, Bir A, Busch SH, Frank RG, Normand SL: The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexes. J Health Econ 2002; 21:373-396
25. Frazier HS, Mosteller MK: Medicine Worth Paying For: Assessing Medical Innovations. Cambridge, Mass, Harvard University Press, 1995
26. Efron B, Tibshirani RJ: An Introduction to the Bootstrap. San Francisco, Chapman & Hall, 1993
27. Fairchild CJ, Rush AJ, Vasavada N, Giles DE, Khatami M: Which depressions respond to placebo? Psychiatry Res 1986; 18:217-226
28. Simon GE, Lin EHB, Katon W, Saunders K, VonKorff M, Walker E, Bush T, Robinson P: Outcomes of "inadequate" antidepressant treatment. J Gen Intern Med 1995; 10:663-670
29. Simon GE, Unützer J, Young BE, Pincus HA: Large medical databases, population-based research, and patient confidentiality. Am J Psychiatry 2000; 157:1731-1737
30. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K: The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998; 55:1128-1132
31. Kessler RC, Zhao S, Katz SJ, Kouzis AC, Frank RG, Edlund M, Leaf P: Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry 1999; 156:115-123
32. American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2000. Washington, DC, APA, 2000